Allurion Technologies Inc. (ALUR)
NYSE NYSE Primary Summary
Allurion Technologies, Inc. (NYSE:ALUR) Short Interest Up 124.0% in February
Allurion Technologies, Inc. (NYSE: ALUR - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 1,065,645 shares, an increase of 124.0% from the February 12th total of 475,725 shares. Based on an average daily volume of 17,038,131 shares,
4 Medical Product Stocks to Watch From a Challenging Industry
The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.
Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript
Allurion Technologies Inc. ( ALUR ) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Tara Brady Shantanu Gaur - Co-Founder, CEO, President, Principal Financial & Accounting Officer and Director Conference Call Participants Joshua Jennings - TD Cowen, Research Division Presentation Operator Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today.
Allurion Technologies Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 2 | $6.42 | $9.43 | $3.01 | 46.88% |
Allurion Technologies Inc. (ALUR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Allurion Technologies Inc. ever had a stock split?
Allurion Technologies Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Shantanu K. Gaur CEO | NYSE Exchange | 02008G201 CUSIP |
| US Country | 134 Employees | - Last Dividend | 3 Jan 2025 Last Split | - IPO Date |
Overview
Allurion Technologies Inc. is a healthcare company dedicated to combating obesity through an innovative weight loss platform aimed at treating individuals who are overweight. With its headquarters in Natick, Massachusetts, Allurion Technologies pioneers in offering an alternative solution to traditional, invasive weight loss procedures. This approach is centered around a holistic program that integrates a unique product—the Allurion Balloon—with a comprehensive suite of digital and telehealth services designed to support patients' weight loss journeys effectively and sustainably.
Products and Services
- The Allurion Balloon
A centerpiece of the Allurion Program, this swallowable and procedure-less intragastric balloon is designed to facilitate weight loss. Unlike surgical alternatives, the Allurion Balloon is a non-invasive device that temporarily resides in the stomach, creating a feeling of fullness, which helps reduce food intake. This innovative approach allows for weight loss without the need for surgery, offering a less intimidating solution for those seeking to lose weight.
- Allurion Virtual Care Suite
Alongside the Allurion Balloon, Allurion Technologies introduces a comprehensive digital health ecosystem to support patients throughout their weight loss journey. This suite includes AI-powered remote patient monitoring tools that allow for personalized and adaptive weight loss plans, a proprietary behavior change program designed to help individuals adopt healthier lifestyle practices, secure messaging for direct communication with healthcare providers, and video telehealth services for convenient access to professional guidance and support. This integrated, patient-centered platform leverages modern technology to enhance the efficacy of the Allurion Program, paving the way for a more engaged, informed, and successful weight management experience.
